Poster Session
An informal session to connect with peers and showcase your research and innovations in antifibrotic R&D. With an audience of 80+ fibrosis experts, including big pharma, biotechs, and academia this is your chance to:
- Demonstrate thought leadership in fibroblast targeting, biomarkers, omics-driven discovery or novel modalities
- Gain visibility for your pipeline or technology among potential partners.
- Receive direct feedback from leaders
- Attract collaborators for licensing or co-development opportunities
Submit a poster today in order to have your research spotlighted in front of this unique audience. Details of submission can be found below - alternatively please contact info@hansonwade.com if you have any questions.
How to Submit Your Poster:
- You must first register your place to attend the 9th Antifibrotic Drug Development Summit
- Submit an abstract for review before October 31 to showcase your poster during the Scientific Poster Session
- You will be notified if your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
Poster Session: 3:30pm, November 17
Submission Deadline: October 31
T&Cs
Posters should not be used for sales and marketing purposes.
If your company offers pay-for services, you will need to submit your poster request to our partnerships team - sponsor@hansonwade.com
All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.
Download the Full Event Guide to Discover:
- 80+ industry leaders from top pharma, biotech, and academic organisations
- Actionable strategies across IPF, MASH, kidney, cardiac, and gut fibrosis, all in one place
- Exclusive data from recent approvals and Phase 2 successes
- Cutting-edge science including spatial omics, ADCs, and collagen-targeted PET imaging with pioneers
- 8+ hours of tailored networking opportunities
